References
- KingRARiddleMAChappellPBEmergence of self-destructive phenomena in children and adolescents during fluoxetine treatmentJ Am Acad Child Adolesc Psychiatry19913021791862016219
- FriedmanEHTricyclic-induced activation/jitterinessJ Clin Psychopharmacol19911163943951770162
- JacksonCWLydiardRBTwo cases of activation/jitteriness associated with TCAsJ Clin Psychopharmacol19901064394402286716
- PohlRYeraganiVKOrtizARaineyJMJrGershonSResponse of tricyclic-induced jitteriness to a phenothiazine in two patientsJ Clin Psychiatry19864784273733676
- YeraganiVKPohlRBalonRTricyclics, akathisia, and jitterinessJ Clin Psychopharmacol1988842953209722
- YeraganiVKPohlRBalonRKulkarniAKeshavanMLow serum iron levels and tricyclic antidepressant-induced jitterinessJ Clin Psychopharmacol1989964474482592591
- US Food Drug AdministrationReports of suicidality in pediatric patients being treated with antidepressant medications for major depressive disorder (MDD)2003 Available from: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm168828.htmAccessed October 24, 2014
- US Food Drug AdministrationWorsening depression and suicidality in patients being treated with antidepressants2004 Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationfor-PatientsandProviders/ucm161696.htmAccessed October 24, 2014
- JuurlinkDNMamdaniMMKoppARedelmeierDAThe risk of suicide with selective serotonin reuptake inhibitors in the elderlyAm J Psychiatry2006163581382116648321
- SimonGESavarinoJSuicide attempts among patients starting depression treatment with medications or psychotherapyAm J Psychiatry200716471029103417606654
- TondoLLepriBBaldessariniRJSuicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorderActa Psychiatr Scand2008118210611518397362
- SimonGESavarinoJOperskalskiBWangPSSuicide risk during antidepressant treatmentAm J Psychiatry20061631414716390887
- HammadTALaughrenTRacoosinJSuicidality in pediatric patients treated with antidepressant drugsArch Gen Psychiatry200663333233916520440
- RotenbergVSFunctional brain asymmetry as a determinative factor in the treatment of depression: theoretical implicationsProg Neuropsychopharmacol Biol Psychiatry20083281772177718775761
- RotenbergVSSearch activity concept: relationship between behavior, health and brain functionsActivitas Nervosa Superior20095111244
- TakeshimaMOkaTAssociation between the so-called “activation syndrome” and bipolar II disorder, a related disorder, and bipolar suggestive features in outpatients with depressionJ Affect Disord2013151119620223790740
- KrausJEHorriganJPCarpenterDJFongRBarrettPSDaviesJTClinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapyJ Affect Disord20101201–3404719439363
- SinclairLIChristmasDMHoodSDAntidepressant-induced jitteriness/anxiety syndrome: systematic reviewBr J Psychiatry2009194648349019478285
- BeasleyCMJrPotvinJHFluoxetine: activating and sedating effectsInt Clin Psychopharmacol1993842712758277147
- AmsterdamJDHornig-RohanMMaislinGEfficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depressionJ Clin Psychiatry19945593944007929020
- HaradaTSakamotoKIshigookaJIncidence and predictors of activation syndrome induced by antidepressantsDepress Anxiety200825121014101918781664
- AkiskalHSHantoucheEGAllilaireJFValidating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II)J Affect Disord2003731–2657412507739
- FriedmanRALeonACExpanding the black box – depression, antidepressants, and the risk of suicideN Engl J Med2007356232343234617485726
- SchneeweissSPatrickARSolomonDHComparative safety of antidepressant agents for children and adolescents regarding suicidal actsPediatrics2010125587688820385637
- SchneeweissSPatrickARSolomonDHVariation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years’ dataArch Gen Psychiatry201067549750620439831
- HammadTAResults of the analysis of suicidality in pediatric trials of newer antidepressants2004 Available from: http://www.fda.gov/ohrms/dockets/ac/04/slides/2004-4065S1_08_FDA-Hammad.pptAccessed September 19, 2014
- YeraganiVKPohlRBalonRRameshCWeinbergPImipramine-induced jitteriness and decreased serum iron levelsNeuropsychobiology19922518101603294
- BeasleyCMJrSaylerMEWeissAMPotvinJHFluoxetine: activating and sedating effects at multiple fixed dosesJ Clin Psychopharmacol19921253283331479050